- Trials with a EudraCT protocol (34)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
34 result(s) found for: Gamma-glutamyltransferase.
Displaying page 1 of 2.
EudraCT Number: 2014-003597-17 | Sponsor Protocol Number: FAR-NP-2014-01 | Start Date*: 2014-11-17 | ||||||||||||||||
Sponsor Name:Josep Llop Talaveron | ||||||||||||||||||
Full Title: Pilot, randomized, double-blind clinical trial to determine the phytosterolaemia in hospitalized patients treated with total parenteral nutrition and gamma-glutamyltransferase alteration | ||||||||||||||||||
Medical condition: Adult hospitalized patients with parenteral nutrition and liver disfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000048-24 | Sponsor Protocol Number: COMB-BO8 | Start Date*: 2018-12-28 |
Sponsor Name:Sahlgrenska University Hospital/VGR | ||
Full Title: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL ON THE EFFICACY OF VARENICLINE AND BUPROPION, IN COMBINATION AND ALONE, FOR THE TREATMENT OF ALCOHOL USE DISORDER | ||
Medical condition: Alcohol Use Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004465-41 | Sponsor Protocol Number: P04612 | Start Date*: 2006-01-27 | |||||||||||
Sponsor Name:SCHERING-PLOUGH | |||||||||||||
Full Title: A multi-center, open-label trial evaluating the Efficacy, Safety and the Impact on Quality of Life of Infliximab Therapy in patients with moderate to severe psoriasis not responding and/or intolera... | |||||||||||||
Medical condition: Moderate to severe psoriasis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002456-90 | Sponsor Protocol Number: 14060802 | Start Date*: 2015-02-13 |
Sponsor Name:Stockholm Centre for Dependency Disorders, Department of Clinical Neuroscience, Karolinska Institutet | ||
Full Title: Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Alcohol Dependence: Effects of the FAAH inhibitor PF-04457845 on Extinction. A Randomized Controlled Trial. | ||
Medical condition: Current Posttraumatic Stress Disorder (PTSD) and Current Alcohol Dependence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003343-11 | Sponsor Protocol Number: GLP1ALCOHOL | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | |||||||||||||
Full Title: Does Glucagon-like Peptide 1 (GLP-1) receptor stimulation reduce alcohol intake in patients with alcohol dependence? | |||||||||||||
Medical condition: Alcohol dependence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007170-30 | Sponsor Protocol Number: TUD-Psslan-031 | Start Date*: 2008-06-03 |
Sponsor Name:Technical University of Dresden, faculty of medicine | ||
Full Title: Untersuchung des Phänotyps und der Funktion proinflammatorischer dendritischer Zellen während einer Therapie der Psoriasis vulgaris mit einem TNFalpha Antagonisten Investigation of phenotype and f... | ||
Medical condition: Psoriasis vulgaris | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2020-000829-55 | Sponsor Protocol Number: PSILO4ALCO | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Psychiatric Centre Copenhagen | ||||||||||||||||||
Full Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial. | ||||||||||||||||||
Medical condition: Alcohol Use Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001431-56 | Sponsor Protocol Number: NUT-2/PBC | Start Date*: 2022-03-07 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Double-blind, randomised, placebo-controlled, phase II dose-finding study comparing different doses of norucholic acid tablets with placebo in the treatment of primary biliary cholangitis in patien... | |||||||||||||
Medical condition: primary biliary cholangitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Prematurely Ended) FI (Prematurely Ended) BE (Completed) FR (Completed) NO (Prematurely Ended) NL (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000085-39 | Sponsor Protocol Number: P04271 | Start Date*: 2005-09-08 | |||||||||||
Sponsor Name:Schering-Plough Research Institute | |||||||||||||
Full Title: An Open-Label, Randomized Efficacy and Safety Study of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis | |||||||||||||
Medical condition: Moderate to severe psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) PT (Completed) DE (Completed) GB (Completed) SE (Completed) ES (Completed) GR (Completed) AT (Completed) FI (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005367-28 | Sponsor Protocol Number: P04563 | Start Date*: 2006-09-18 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a division of Schering Corporation | |||||||||||||
Full Title: A Long-Term Efficacy and Safety Study of Infliximab in the Treatment of Moderate to Severe Plaque-type Psoriasis | |||||||||||||
Medical condition: Moderate to severe plaque-type psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) FI (Prematurely Ended) ES (Prematurely Ended) SE (Prematurely Ended) BE (Completed) DK (Prematurely Ended) PT (Prematurely Ended) GR (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000535-26 | Sponsor Protocol Number: P05133 | Start Date*: 2007-06-04 | |||||||||||
Sponsor Name:SCHERING-PLOUGH | |||||||||||||
Full Title: SwiTching from etAnercept to iNfliximab in the treatment of moderate to severe psoriasis; a multi-center, open label trial evaluating the efficacy, tOlerance and safety (TANGO) | |||||||||||||
Medical condition: Patients with moderate to severe psoriasi. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011041-12 | Sponsor Protocol Number: ET-A-018-09 | Start Date*: 2009-07-23 | |||||||||||
Sponsor Name:Pharma Mar S.A. | |||||||||||||
Full Title: Étude multicentrique de phase Ib-II en escalade de dose de la trabectédine (Yondelis®) en association avec l’oxaliplatine chez des patientes atteintes d’un cancer de l’ovaire avancé prétraité. | |||||||||||||
Medical condition: Pretreated Advanced Ovarian Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001371-37 | Sponsor Protocol Number: GDM-TREAT | Start Date*: 2012-07-10 | ||||||||||||||||
Sponsor Name:Dr. med. Tina Vilsbøll | ||||||||||||||||||
Full Title: The impact of liraglutide on glucose tolerance and the risk of type 2 diabetes in women with previous gestational diabetes mellitus | ||||||||||||||||||
Medical condition: Gestational diabetes mellitus Non-alcoholic fatty liver disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-005006-62 | Sponsor Protocol Number: ASZ-001 | Start Date*: 2019-12-10 | |||||||||||
Sponsor Name:Albert Schweitzer hospital | |||||||||||||
Full Title: Pharmacokinetics of Paracetamol before and after Roux-en-Y gastric bypass | |||||||||||||
Medical condition: Roux-en-Y gastric bypass | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003419-68 | Sponsor Protocol Number: HepBTer | Start Date*: 2020-12-18 | |||||||||||||||||||||||||||||||
Sponsor Name:Academic Medical Center (AMC) | |||||||||||||||||||||||||||||||||
Full Title: From fungus to virus, a phase 2a clinical trial investigating the safety and efficacy of terbinafine in chronic hepatitis B patients | |||||||||||||||||||||||||||||||||
Medical condition: Chronic hepatitis B infection | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002189-12 | Sponsor Protocol Number: P04422 | Start Date*: 2005-12-07 | |||||||||||
Sponsor Name:Integrated Therapeutics Group, Inc. - A subsidiary of Schering-Plough Corp. | |||||||||||||
Full Title: A randomized, multicenter, international, open-label study of infliximab plus methotrexate versus methotrexate (MTX) alone for the treatment of MTX naïve subjects with Active Psoriatic Arthritis Ra... | |||||||||||||
Medical condition: Pacienti s aktívnou psoriatickou artiritídou. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) LT (Completed) SI (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000982-51 | Sponsor Protocol Number: P05336 | Start Date*: 2009-07-01 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | |||||||||||||
Full Title: Infliximab as First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial | |||||||||||||
Medical condition: Moderate-to-severe active axial spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) AT (Completed) BE (Completed) DE (Completed) HU (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004287-30 | Sponsor Protocol Number: LAL-CL06 | Start Date*: 2014-06-19 | |||||||||||
Sponsor Name:Alexion Pharmaceuticals inc | |||||||||||||
Full Title: A Multicenter, Open-Label Study of Sebelipase Alfa in Patients with Lysosomal Acid Lipase Deficiency | |||||||||||||
Medical condition: Lysosomal Acid Lipase Deficiency (LALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) ES (Completed) GB (Completed) IT (Prematurely Ended) DE (Completed) BE (Completed) HR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000454-12 | Sponsor Protocol Number: P05315 | Start Date*: 2009-03-03 | |||||||||||
Sponsor Name:Schering Plough Research Institute, a Division of Schering Corporation | |||||||||||||
Full Title: A Study of Dose Optimization of Infliximab in the Treatment of Moderate to Severe Plaque Psoriasis. | |||||||||||||
Medical condition: Moderate to severe plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Prematurely Ended) DK (Completed) HU (Prematurely Ended) FR (Prematurely Ended) GR (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002670-22 | Sponsor Protocol Number: P04807 | Start Date*: 2007-10-31 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a division of Schering Corporation | |||||||||||||
Full Title: Comparison of the Efficacy and Safety of Infliximab, as Monotherapy or in Combination With Azathioprine, Versus Azathioprine Monotherapy in Moderate to Severe Active Ulcerative Colitis (Part 1). C... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Prematurely Ended) BE (Completed) HU (Prematurely Ended) CZ (Completed) PT (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) IT (Prematurely Ended) SK (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
